Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2.
Meyers Primary Care Institute; Department of Medicine, Division of Geriatric Medicine; Department of Medicine, Division of Cardiovascular Medicine
Medical Subject Headings
Age Factors; Aged; Aged, 80 and over; Cerebral Hemorrhage; Female; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Tissue Plasminogen Activator
Health Services Research | Medicine and Health Sciences
In a retrospective cohort of patients treated in community hospitals, tissue plasminogen activator (t-PA) was associated with decreased odds of in-hospital death or nonfatal stroke. However, the relative benefit was less evident in older patients and women, and some older subgroups did not benefit from treatment.
Rights and Permissions
Citation: Am J Cardiol. 2001 Mar 1;87(5):627-30, A9.
Angeja, Brad G.; Rundle, A C; Gurwitz, Jerry H.; Gore, Joel M.; and Barron, Hal V., "Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2." (2001). Meyers Primary Care Institute Publications and Presentations. 85.